Yuhan shares once hit 200,000 won

Shares of Yuhan Corporation, one of the leading pharmaceutical firms in Korea, briefly surpassed 200,000-won level on August 3 thanks to robust sales of Levanex, a homegrown antiulcerant, opening a new chapter for the local pharmaceutical industry, analysts said.

Shares of Yuhan rose 1.58 percent to close at 198,000 won on the Seoul bourse. The results were released after the market closed.
...